当前位置:首页 - 行情中心 - 华大基因(300676) - 财务分析 - 现金流量表

华大基因

(300676)

  

流通市值:202.20亿  总市值:203.30亿
流通股本:4.16亿   总股本:4.18亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,221,551,326.831,381,650,198.94603,829,040.383,507,911,150.9
  收到的税费返还428,944.25423,280.12423,278.572,907,422.08
  收到其他与经营活动有关的现金216,310,532.78106,792,822.4648,234,574.46352,789,344.21
  经营活动现金流入小计2,438,290,803.861,488,866,301.52652,486,893.413,863,607,917.19
  购买商品、接受劳务支付的现金1,322,372,298.42856,595,638.9492,198,590.081,576,082,330.17
  支付给职工以及为职工支付的现金865,417,929.27568,693,422.12315,971,121.411,153,821,278.81
  支付的各项税费94,872,008.871,442,003.2338,498,076.35206,939,887.39
  支付其他与经营活动有关的现金592,301,658.12405,972,953.4202,912,883.28831,041,595.31
  经营活动现金流出小计2,874,963,894.611,902,704,017.651,049,580,671.123,767,885,091.68
  经营活动产生的现金流量净额-436,673,090.75-413,837,716.13-397,093,777.7195,722,825.51
二、投资活动产生的现金流量:
  收回投资收到的现金4,693,110,320.323,127,398,450.951,822,875,351.4511,960,221,087.35
  取得投资收益收到的现金57,450,047.0137,699,529.6120,132,426.6697,832,649.44
  处置固定资产、无形资产和其他长期资产收回的现金净额3,529,744.893,304,010.28112,034.57562,147.67
  投资活动现金流入小计4,754,090,112.223,168,401,990.841,843,119,812.6812,058,615,884.46
  购建固定资产、无形资产和其他长期资产支付的现金275,362,984.95251,850,582.61170,600,959.19529,480,642.08
  投资支付的现金5,237,461,623.83,437,191,534.051,894,099,219.4611,843,551,048.01
  支付其他与投资活动有关的现金12,001,775.7312,001,775.73--
  投资活动现金流出小计5,524,826,384.483,701,043,892.392,064,700,178.6512,373,031,690.09
  投资活动产生的现金流量净额-770,736,272.26-532,641,901.55-221,580,365.97-314,415,805.63
三、筹资活动产生的现金流量:
  取得借款收到的现金570,960,000570,960,000570,960,000192,796,406.9
  收到其他与筹资活动有关的现金69,200,21569,200,215-53,078,767.5
  筹资活动现金流入小计640,160,215640,160,215570,960,000245,875,174.4
  偿还债务支付的现金418,441,873.18224,963,873.187,585,692.7337,730,696.54
  分配股利、利润或偿付利息支付的现金13,440,306.288,573,749.142,881,529.1453,544,931.44
  其中:子公司支付给少数股东的股利、利润---3,181,500
  支付其他与筹资活动有关的现金28,233,401.7819,449,739.5911,222,169.46837,751,898.37
  筹资活动现金流出小计460,115,581.24252,987,361.9121,689,391.33929,027,526.35
  筹资活动产生的现金流量净额180,044,633.76387,172,853.09549,270,608.67-683,152,351.95
四、汇率变动对现金及现金等价物的影响7,022,116.6111,951,421.831,140,128.545,121,479.49
五、现金及现金等价物净增加额-1,020,342,612.64-547,355,342.76-68,263,406.51-856,723,852.58
  加:期初现金及现金等价物余额2,698,417,224.42,698,417,224.42,698,417,224.43,555,141,076.98
  期末现金及现金等价物余额1,678,074,611.762,151,061,881.642,630,153,817.892,698,417,224.4
补充资料:
  净利润-4,144,746.19--912,101,083.16
  资产减值准备-123,902,940.59-438,444,688.41
  固定资产和投资性房地产折旧-185,266,494.73-362,164,765.23
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-185,266,494.73-362,164,765.23
  无形资产摊销-34,315,001.67-67,701,502.82
  长期待摊费用摊销-21,560,556.68-63,033,131.31
  处置固定资产、无形资产和其他长期资产的损失-1,785,189.01-631,684.81
  固定资产报废损失-2,645,775.93-5,686,770.66
  公允价值变动损失--9,210,174.71-33,175,650.35
  财务费用-9,285,559.84--10,116,817.26
  投资损失--18,665,756.39-43,626,260.23
  递延所得税--50,545,313.11-22,868,842.15
  其中:递延所得税资产减少--38,588,539.49-11,109,403.54
    递延所得税负债增加--11,956,773.62-11,759,438.61
  存货的减少-50,000,311.05--34,200,452.89
  经营性应收项目的减少--336,509,883.07--438,842,458.36
  经营性应付项目的增加--450,216,467.1-284,489,065.92
  其他---115,499,013.36
  不涉及现金收支的投资和筹资活动金额其他项目-52,537,066.4-15,402,331.25
  现金的期末余额-2,151,061,881.64-2,698,417,224.4
  减:现金的期初余额-2,698,417,224.4-3,555,141,076.98
  现金及现金等价物的净增加额--547,355,342.76--856,723,852.58
公告日期2025-10-242025-08-232025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑